Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of disease
Crossref DOI link: https://doi.org/10.1038/nrd.2017.231
Published Online: 2017-12-22
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schuck, Robert N.
Pacanowski, Michael
Woodcock, Janet
Zineh, Issam
Text and Data Mining valid from 2017-12-22
Article History
First Online: 22 December 2017
Competing interests
: The authors declare no competing financial interests.